Ulland Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
200
0.18% 70
2026
Q1
$184K Hold
200
0.16% 69
2025
Q4
$215K Sell
200
-7
-3% -$6.69K 0.17% 63
2025
Q3
$158K Buy
207
+7
+4% +$5.21K 0.12% 68
2025
Q2
$156K Hold
200
0.12% 72
2025
Q1
$165K Hold
200
0.14% 70
2024
Q4
$154K Hold
200
0.1% 66
2024
Q3
$177K Sell
200
-14
-7% -$12.6K 0.13% 62
2024
Q2
$194K Hold
214
0.13% 62
2024
Q1
$166K Buy
214
+14
+7% +$9.96K 0.13% 67
2023
Q4
$117K Hold
200
0.12% 73
2023
Q3
$107K Hold
200
0.12% 73
2023
Q2
$94K Hold
200
0.1% 81
2023
Q1
$69K Hold
200
0.08% 80
2022
Q4
$73K Hold
200
0.09% 79
2022
Q3
$65K Hold
200
0.07% 80
2022
Q2
$65K Hold
200
0.07% 86
2022
Q1
$57K Hold
200
0.04% 101
2021
Q4
$55K Buy
+200
New +$50.7K 0.04% 99

Other funds holding LLY

Ulland Investment Advisors's LLY Position: Q2 2026 in Review

Ulland Investment Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 200 shares worth $240K. The position accounts for 0.18% of the portfolio, ranked #70.

Ulland Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ulland Investment Advisors held 200 shares of Eli Lilly worth $240K as of Q2 2026.
  • Ulland Investment Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.18% of Ulland Investment Advisors's portfolio in Q2 2026, its #70 holding.
  • Ulland Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.